Tubulosine is a natural product that has been isolated from the Chinese medicinal plant *Tripterygium wilfordii*. It exhibits a range of biological activities, including anti-inflammatory, immunosuppressive, and anti-cancer effects. Its complex structure, composed of a highly modified indole alkaloid scaffold, has stimulated significant interest in its synthetic and medicinal chemistry. The compound is known to inhibit the activity of several enzymes, including protein kinases and DNA topoisomerases. Research into tubulosine is ongoing, with a focus on developing its potential as a therapeutic agent for various diseases.'
tubulosine: indole derivative of main alkaloids of ipecac; RN given refers to cpd with unspecified isomeric designation; structure
tubulosine : A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 and a hydroxy group at the 8' position.
ID Source | ID |
---|---|
PubMed CID | 72341 |
CHEMBL ID | 518568 |
CHEBI ID | 9775 |
SCHEMBL ID | 1920742 |
MeSH ID | M0054833 |
Synonym |
---|
CHEBI:9775 , |
nsc-131547 |
1h-pyrido[3, 1-[[(2s,3r,11bs)-3-ethyl-1,3,4,6,7,11b-hexahydro- 9,10-dimethoxy-2h-benzo[a]quinolizin-2-yl]methyl]- 2,3,4,9-tetrahydro-, (1r)- |
nsc131547 , |
tubulosan-8'-ol,11-dimethoxy- |
10,11-dimethoxytubulosan-8'-ol |
tubulosan-8'-ol, 10,11-dimethoxy- |
1h-pyrido[3,4-b]indol-6-ol, 1-[[(2s,3r,11bs)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo[a]quinolizin-2-yl]methyl]-2,3,4,9-tetrahydro-, (1r)- |
(1r)-1-[[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizin-2-yl]methyl]-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-6-ol |
C09248 |
2632-29-3 |
tubulosine |
(1r)-1-[[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1h-pyrido[2,1-a]isoquinolin-2-yl]methyl]-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-6-ol |
NCI131547 |
NCI60_000694 |
NCISTRUC2_001820 |
NCISTRUC1_001471 |
SR-02000000201-1 |
CHEMBL518568 |
unii-112a6z7sn5 |
nsc 131547 |
10,11-dimethoxytubulosanol |
112a6z7sn5 , |
SCHEMBL1920742 |
1h-pyrido(3,4-b)indol-6-ol, 1-((3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo(a)quinolizin-2-yl)methyl)-2,3,4,9-tetrahydro-, (2s-(2.alpha.(s*),3.beta.,11b.beta.))- |
(1r)-1-(((2s,3r,11bs)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo(a)quinolizin-2-yl)methyl)-2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indol-6-ol |
(-)-tubulosine |
1h-pyrido(3,4-b)indol-6-ol, 1-(((2s,3r,11bs)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo(a)quinolizin-2-yl)methyl)-2,3,4,9-tetrahydro-, (1r)- |
bdbm50480281 |
Q27108491 |
(1r)-1-[[(2s,3r,11bs)-3-ethyl-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-2h-benzo[a]quinolizin-2-yl]methyl]-2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-6-ol |
DTXSID701100319 |
Excerpt | Relevance | Reference |
---|---|---|
" Dose-response experiments in primary cells confirmed pathway selectivity, but importantly also revealed differential inhibition of cell types and new druggability trends across multiple compounds." | ( High-content single-cell drug screening with phosphospecific flow cytometry. Clutter, MR; Crane, JM; Krutzik, PO; Nolan, GP, 2008) | 0.35 |
Class | Description |
---|---|
isoquinoline alkaloid | Any alkaloid that has a structure based on an isoquinoline nucleus. They are derived from the amino acids like tyrosine and phenylalanine. |
secondary amino compound | A compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups. |
tertiary amino compound | A compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups. |
beta-carbolines | Any pyridoindole containing a beta-carboline skeleton and their hydrogenated derivatives |
isoquinolines | A class of organic heteropolycyclic compound consisting of isoquinoline and its substitution derivatives. |
phenols | Organic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID376034 | Cytotoxicity against human multidrug resistant KB cells in presence of vinblastine | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336511 | Antitumor activity against Agrobacterium tumefaciens-induced crown gall tumors in potato by disk test | |||
AID376038 | Cytotoxicity against human SK-N-SH cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID376030 | Cytotoxicity against human BC1 cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336510 | Toxicity in brine shrimp | |||
AID376028 | In vivo antitumor activity against mouse L1210 cells assessed as increase in life span at 2 mg/kg | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID376033 | Cytotoxicity against human KB cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID397122 | Inhibition of HIV1 RT | |||
AID1616252 | Cytotoxicity against human SKOV3 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2019 | Journal of natural products, 09-27, Volume: 82, Issue:9 | Octahydro-Protoberberine and Protoemetine-Type Alkaloids from the Stems of |
AID1616250 | Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2019 | Journal of natural products, 09-27, Volume: 82, Issue:9 | Octahydro-Protoberberine and Protoemetine-Type Alkaloids from the Stems of |
AID495065 | Inhibition of JAK-mediated interferon-gamma-induced Stat1 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM | 2008 | Nature chemical biology, Feb, Volume: 4, Issue:2 | High-content single-cell drug screening with phosphospecific flow cytometry. |
AID376031 | Cytotoxicity against human Lu1 cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID376035 | Cytotoxicity against human multidrug resistant KB cells in absence of vinblastine | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336513 | Cytotoxicity against human 9KB cells | |||
AID336517 | In vivo antitumor activity against mouse 3PS cells at 0.25 mg/kg, relative to control | |||
AID376037 | Cytotoxicity against human SW626 cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID376032 | Cytotoxicity against human Col2 cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336512 | Cytotoxicity against mouse 9PS cells | |||
AID376036 | Cytotoxicity against human LNCAP cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336515 | Cytotoxicity against human MCF7 cells | |||
AID1616251 | Cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | 2019 | Journal of natural products, 09-27, Volume: 82, Issue:9 | Octahydro-Protoberberine and Protoemetine-Type Alkaloids from the Stems of |
AID376039 | Cytotoxicity against mouse M109 cells | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID336514 | Cytotoxicity against human A549 cells | |||
AID495066 | Inhibition of anisomycin-induced p38 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM | 2008 | Nature chemical biology, Feb, Volume: 4, Issue:2 | High-content single-cell drug screening with phosphospecific flow cytometry. |
AID376029 | In vivo antitumor activity against mouse P388 cells assessed as increase in life span at 2 mg/kg | 1999 | Journal of natural products, Sep, Volume: 62, Issue:9 | 1',2',3',4'-tetradehydrotubulosine, a cytotoxic alkaloid from Pogonopus speciosus. |
AID495064 | Inhibition of JAK-mediated GM-CSF-induced Stat5 phosphorylation in human U937 cells by Phospho-Flow cytometry at 20 uM | 2008 | Nature chemical biology, Feb, Volume: 4, Issue:2 | High-content single-cell drug screening with phosphospecific flow cytometry. |
AID336516 | Cytotoxicity against human HT-29 cells | |||
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (23.08) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.67) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 16 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |